Cancer cell-intrinsic inflammasome protein ASC links innate immunity with mitochondrial metabolism in driving pancreatic cancer.

Saved in:
Bibliographic Details
Title: Cancer cell-intrinsic inflammasome protein ASC links innate immunity with mitochondrial metabolism in driving pancreatic cancer.
Authors: Chey YCJ; South Australian ImmunoGENomics Cancer Institute (SAiGENCI), The University of Adelaide, Adelaide, SA, Australia., Kashgari B; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular Translational Science, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., McLeod L; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular Translational Science, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Radford GA; South Australian ImmunoGENomics Cancer Institute (SAiGENCI), The University of Adelaide, Adelaide, SA, Australia., Gearing LJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular Translational Science, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Dawson RE; South Australian ImmunoGENomics Cancer Institute (SAiGENCI), The University of Adelaide, Adelaide, SA, Australia., Kharbanda M; South Australian ImmunoGENomics Cancer Institute (SAiGENCI), The University of Adelaide, Adelaide, SA, Australia., Lundy J; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular Translational Science, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.; Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Clayton, VIC, Australia.; Peninsula Clinical School, School of Translational Medicine, Monash University, Frankston, VIC, Australia., Croagh D; Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Clayton, VIC, Australia., Girard-Guyonvarc'h C; Division of Rheumatology, University Hospital of Geneva, Geneva, Switzerland.; Department of Pathology and Immunology, University of Geneva School of Medicine, Geneva, Switzerland., Gabay C; Division of Rheumatology, University Hospital of Geneva, Geneva, Switzerland.; Department of Pathology and Immunology, University of Geneva School of Medicine, Geneva, Switzerland., Pereira BA; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales (UNSW), Kensington, Sydney, NSW, Australia., Herrmann D; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales (UNSW), Kensington, Sydney, NSW, Australia., Timpson P; Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales (UNSW), Kensington, Sydney, NSW, Australia., Finnie JW; School of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia., Saad MI; South Australian ImmunoGENomics Cancer Institute (SAiGENCI), The University of Adelaide, Adelaide, SA, Australia., Bhuva DD; South Australian ImmunoGENomics Cancer Institute (SAiGENCI), The University of Adelaide, Adelaide, SA, Australia.; The University of Queensland, Brisbane, QLD, Australia., Franklin BS; Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany., Schmidt FI; Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany., Jenkins BJ; South Australian ImmunoGENomics Cancer Institute (SAiGENCI), The University of Adelaide, Adelaide, SA, Australia. brendan.jenkins@adelaide.edu.au.; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia. brendan.jenkins@adelaide.edu.au.; Department of Molecular Translational Science, School of Clinical Sciences, Monash University, Clayton, VIC, Australia. brendan.jenkins@adelaide.edu.au.
Source: Nature communications [Nat Commun] 2026 Feb 07; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 07.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-026-69398-w